Browse by all authors Browse By Author Name - Gill,+Devinder+S.

Browse Results (8 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Hourigan, Matthew J., Doecke, James, Mollee, Peter N., Gill, Devinder S., Norris, Debra, Johnson, David W. and Gandhi, Maher K. (2008) A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation. British Journal of Haematology, 141 6: 904-907. doi:10.1111/j.1365-2141.2008.07149.x 83   12 Cited 12 times in Scopus12 0
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, H.Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy, Fan, Helen Mar and Gill, Devinder S. (2012) A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. British Journal of Haematology, 157 6: 766-769. doi:10.1111/j.1365-2141.2012.09080.x 57   3 Cited 4 times in Scopus4 1
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S. (2011). A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. In: ASH Annual Meeting Abstracts 2011. 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, (1700-1700). Dec 10-13, 2011. 38   0
Spencer, Andrew, Prince, H. Miles, Roberts, Andrew W., Prosser, Ian W., Bradstock, Kenneth F., Coyle, Luke, Gill, Devinder S., Horvath, Noemi, Reynolds, John and Kennedy, Nola (2009) Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. Journal of Clinical Oncology, 27 11: 1788-1793. doi:10.1200/JCO.2008.18.8573 140   167 Cited 194 times in Scopus194 0
Mutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012) High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease. American Journal of Blood Research, 2 1: 66-70. 47 3
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. In: P. Halloran, American Journal of Transplantation: Proceedings of the American Transplant Congress 2007. American Transplant Congress 2007, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 157   0 0
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. In: American Journal of Transplantation. American Transplant Congress, San Francisco, CA, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 82   0 0
Tey, Siok-Keen, Marlton, Paula V., Hawley, Carmel M., Norris, Debra and Gill, Devinder S. (2008) Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen. American Journal of Hematology, 83 4: 330-333. doi:10.1002/ajh.21062 61   13 Cited 15 times in Scopus15 0